SPRYCEL vs VENCLEXTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. SPRYCEL and VENCLEXTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	SPRYCEL	VENCLEXTA
Rating	72/100	72/100
Pharmacy pays	~$839.19 /30	—
Type	RX	RX
Active ingredient	DASATINIB	VENETOCLAX
Manufacturer	Bristol Myers Squibb	Abbvie
Dosage forms	Tablet	Tablet, Kit
Drug class	Kinase Inhibitor	—
Boxed warning	None	None
Treats	Lymphoid Leukemia, Myeloid Leukemia	Lymphoid Leukemia

sprycel venclexta

Rating

72/100

Pharmacy pays

~$839.19 /30

—

Type

Active ingredient

DASATINIB

VENETOCLAX

Manufacturer

Bristol Myers Squibb

Abbvie

Dosage forms

Tablet

Tablet, Kit

Drug class

Kinase Inhibitor

—

Boxed warning

None

Treats

Lymphoid Leukemia, Myeloid Leukemia

Lymphoid Leukemia

Frequently asked questions

Which is better-rated, Sprycel or Venclexta?

Sprycel and Venclexta are tied at 3.6 out of 5 by our independent rating.

What is the difference between Sprycel and Venclexta?

Sprycel contains Dasatinib, while Venclexta contains Venetoclax — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.